Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | VAV1 |
| Upstream (Parents) |
|---|
| (<<) IKZF1 → VAV1 |
| (<<) SP140 → VAV1 |
| (<<) FLI1 → VAV1 |
| (<<) HCLS1 → VAV1 |
| Downstream (Children) |
|---|
| VAV1 → PEG3 (>>) |
| VAV1 → IRX1 (>>) |
| VAV1 → SOX6 (>>) |
| VAV1 → EOMES (>>) |
| VAV1 → MAF (>>) |
| VAV1 → TFEC (>>) |
| VAV1 → DLX6 (>>) |
| VAV1 → TRPS1 (>>) |
| VAV1 → XBP1 (>>) |
| VAV1 → IRF6 (>>) |
| VAV1 → IRF1 (>>) |
| VAV1 → IRF7 (>>) |
| VAV1 → DLX2 (>>) |
| VAV1 → STAT4 (>>) |
| VAV1 → CEBPA (>>) |
| VAV1 → HHEX (>>) |
| VAV1 → VDR (>>) |
| VAV1 → RBCK1 (>>) |
| VAV1 → TEAD1 (>>) |
| VAV1 → POU2F2 (>>) |
| VAV1 → CBFA2T3 (>>) |
| VAV1 → BATF (>>) |
